The Medical Devices sector report, “Reproductive Health Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Reproductive Health Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Reproductive Health Devices includes Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices and Assisted Reproductive Technology Devices.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Reproductive Health Devices includes Endometrial Ablation Devices, Female Sterilization Devices, Reversible Contraceptive Devices and Assisted Reproductive Technology Devices.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Reproductive Health Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Reproductive Health Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Reproductive Health Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Reproductive Health Devices - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3Daughters Inc
- Ablatus Therapeutics Ltd
- AdneXXA LLC
- Agile Therapeutics Inc
- AltaScience Limited
- Alydia Health Inc
- Autoivf Inc
- Bayer AG
- Bioceptive Inc
- Biorings LLC
- BioTex Inc
- Ceragenix Pharmaceuticals, Inc. (Inactive)
- Contrel Europe NV
- Dare Bioscience Inc
- Dartmouth College
- Emblation Ltd
- EVE Medical Systems Ltd
- Evestra Inc
- Evofem Biosciences Inc
- Femasys Inc
- FemSuite LLC
- Ghent University
- Healthcare Enterprise Group PLC (Inactive)
- Hemosquid SAS
- Hera Health Solutions
- HLL Lifecare Ltd
- Idoman Teoranta
- Impres Medical, Inc.
- INVO Bioscience Inc
- Japanese Organization for Medical Device Development Inc
- Johns Hopkins University
- Keratin Biosciences Inc
- Laboratoire HRA Pharma SAS
- Lubrizol Life Science Health
- May Health
- Memorial Sloan Kettering Cancer Center
- Memphasys Ltd
- Menorrx LLC
- Merck & Co Inc
- Merck Serono SA
- NextGem Inc
- Nipro Corp
- Novomedics L L C
- OCON Medical Ltd
- OncoGenesis
- Otago Innovation Ltd
- Pfizer Inc
- Sebela Pharmaceuticals Inc
- Shandong Junxiu Biotechnology Co Ltd
- Teva Pharmaceuticals USA Inc
- Teva Women's Health
- University of California San Diego
- University of Cape Town
- University of Minnesota
- University of Oxford
- University of Texas at Austin
- University of Texas Health Science Center at San Antonio
- University of Washington
- Womed
- Yale University
- ZR-Operculum, Inc.